Production (Stage)
CareDx, Inc
CDNA
$16.95
-$0.16-0.94%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Revenue | 346.42M | 333.79M | 312.78M | 297.08M | 275.11M |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 346.42M | 333.79M | 312.78M | 297.08M | 275.11M |
Cost of Revenue | 112.11M | 109.63M | 107.07M | 104.03M | 101.97M |
Gross Profit | 234.31M | 224.16M | 205.71M | 193.06M | 173.14M |
SG&A Expenses | 204.52M | 208.73M | 193.51M | 197.33M | 199.31M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 388.85M | 390.77M | 374.72M | 377.02M | 377.50M |
Operating Income | -42.43M | -56.98M | -61.95M | -79.94M | -102.39M |
Income Before Tax | 59.31M | 49.63M | -146.48M | -162.84M | -186.49M |
Income Tax Expenses | 451.00K | 310.00K | 304.00K | 24.00K | -66.00K |
Earnings from Continuing Operations | 58.86 | 49.32 | -146.79 | -162.86 | -186.42 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 58.86M | 49.32M | -146.79M | -162.86M | -186.42M |
EBIT | -42.43M | -56.98M | -61.95M | -79.94M | -102.39M |
EBITDA | -28.46M | -42.79M | -47.48M | -65.28M | -87.61M |
EPS Basic | 1.08 | 0.89 | -2.76 | -3.06 | -3.49 |
Normalized Basic EPS | -0.36 | -0.55 | -0.57 | -0.78 | -1.04 |
EPS Diluted | 0.98 | 0.79 | -2.77 | -3.06 | -3.49 |
Normalized Diluted EPS | -0.35 | -0.53 | -0.57 | -0.78 | -1.04 |
Average Basic Shares Outstanding | 214.65M | 211.07M | 210.18M | 211.46M | 213.11M |
Average Diluted Shares Outstanding | 218.58M | 215.01M | 210.18M | 211.46M | 213.11M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |